Effects of neuroactive steroids on the recombinant GABAA receptor in Xenopus oocyte

University dissertation from Umeå : Medicinsk fakultet

Abstract: Introduction: Neuroactive steroids represent a class of both synthetic and naturally occurring steroids that have an effect on neural function. In addition to classical genomic mechanism by the hormones progesterone, deoxycorticosterone and testosterone 3?-OH metabolites of these hormones enhance GABAA receptor through rapid non-genomic mechanism. The site(s) of action of these neuroactive steroids namely 3?-OH-5?-pregnan-20 one, (3?,5?)-3,21-deoxycorticosterone(3?5?-THDOC) and 5? androstane-3?,17?-diol on GABAA receptor are distinct from that of benzodiazepines and barbiturate binding sites. The modulation site(s) has a well-defined structure activity relationship with a 3?-hydroxy and a 20-ketone configuration in the pregnane molecule required for agonistic action. Pregnenolone sulfate is a noncompetitive GABAA receptor antagonist and inhibit GABA activated Cl- current in an activation dependant manner. 3?-hydroxy A-ring reduced pregnane steroids are also GABAA receptor antagonist and inhibit GABAA receptor function and its potentiation induced by their 3?-diesteromers in a noncompetitive manner.Aim: The aim was to investigate if the effect of GABA, pentobarbital antagonism by bicuculline and if the effect of GABA-agonist and antagonist neuroactive steroids including pregnenolone sulfate is dependant on the ?-subunits of GABAA receptor. Furthermore, the studies aimed at investigating the binding site of pregnenolone sulfate and if its effect is dependent on ?-subunit. In addition, the inhibitory effect of pregnenolone sulfate and 3?-hydroxy steroids has been characterized. We also wanted to investigate if the neuroactive steroids effect vary between the human and rat recombinant ?1?2?2L receptors and between the long (L) and short (S) variants of ?2-subunit.Method: Experiments were performed by the two electrodes voltage-clamp technique using oocytes of Xenopus laevis expressed with recombinant GABAA receptors containing ?1, ?4 or ?5, ?2, ?2L and ?2S-subunits.Results: There was no difference between the ?1, ?4 and ?5-containing subunits regarding GABA and pentobarbital inhibition by bicuculline. GABA-activated current in the binary ?? was potent than that of ternary ??? receptor. Unlike Zn2+ effect, inhibition by pregnenolone sulfate on the GABAA receptor is not dependant on the ?-subunit. It is likely that the 2’ residue closest to the N-terminus of the protein at M2 helix on both ?1 and ?2 subunit are critical to the inhibitory actions of PS and the function of Cl- channels. Point mutation at M2 helix of the ?2-subunit (b2A252S) can dramatically reduce the inhibitory effect of PS on the GABAA receptors without affecting the inhibitory properties of 3?-hydroxysteroids. Agonist and antagonist steroids also varied in their efficacy between the human and rat ?1?2?2L receptor. Neuroactive steroids also showed difference between human ?2L and ?2S-containing receptor.Conclusions: GABA and pentobarbital antagonism by bicuculline is not dependant on ?-subunit. Pregnenolone sulfate binding site is different from that of Zn2+. 3?-hydroxysteroids and pregnenolone sulfate inhibit GABAA receptor through different mechanisms. Neuroactive steroids also differ between species and between the long and short variant of ?- subunit.

  CLICK HERE TO DOWNLOAD THE WHOLE DISSERTATION. (in PDF format)